Bioavailability Studies

Amount of a substance that becomes available (reaches the target organ or systemic circulation) to an organism's body for bioactivity when introduced through ingestion, inhalation, injection, or skin contact. Rate of bioavailability depends on factors such as the type of the substance and the composition of diet.

By analyzing global market trends with data from 2012 and 2013 projections of compound annual growth rates (CAGRs) through 2018.The North American market is expected to reach around $79 billion in 2017 and is expected to raise at a 7.9% compound annual growth rate to nearly $108 billion in 2020.

  • Bioavailability of Liposomes
  • Prodrugs
  • Oral drugs
  • Therapeutic systems
  • Liposomal drug delivery

Related Conference of Bioavailability Studies

July 03-05, 2017

4th Annual Congress on Drug Discovery & Designing

Bangkok, Thailand
August 10-12, 2017

8th Asian Biologics and Biosimilars Congress

Beijing, China
Sep 20-21, 2017

10th Pharmacovigilance Congress

Charlotte, North Carolina, USA
September 25-26, 2017(10 Plenary Forums- 1 Event)

7th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR

Chicago, Illinois, USA
September 25-26, 2017
(10 Plenary Forums - 1Event)

6th International Conference and Exhibition on GMP, GCP & Quality Control

Chicago, Illinois, USA
October 02-04, 2017

World Congress on Antibiotics: R&D, Market

Atlanta, USA
October 16-18, 2017

12th World Pharma Congress

Budapest, Hungary
October 16-18, 2017

11th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Baltimore, Maryland, USA
October 16-17, 2017

10th International Conference and Exhibition on Biologics and Biosimilars

San Francisco, California, USA
November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
Dec 14-16, 2017

7th Global Mass Spectrometry Congress

Dubai, UAE

Bioavailability Studies Conference Speakers

Recommended Sessions

Related Journals

Are you interested in